The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: A review of the evidence

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 5, 2009, Pages 328-333

  Vardavas, Constantine I ^a   Panagiotakos, Demosthenes B ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Cardiovascular disease; CRP; Inflammation; Passive smoking; Vascular dysfunction

Indexed keywords

ACROLEIN; C REACTIVE PROTEIN; CARCINOGEN; CHEMICAL AGENT; FIBRINOGEN; HOMOCYSTEINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; LOW DENSITY LIPOPROTEIN; TOXIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; FIBRINOGEN BLOOD LEVEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; OXIDATIVE STRESS; PASSIVE SMOKING; REVIEW; SYSTOLIC BLOOD PRESSURE; THROMBOGENESIS; VASCULITIS;

EID: 74849118823     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528110908050328     Document Type: Review

References (62)

1. Lin, C.P.; Chen, Y.H.; Leu, H.B.; Lin, S.J.; Chen, Y.L.; Huang, S.L.; Chen, J.W. Anti-inflammatory strategies for homocysteine-related cardiovascular disease. Front Biosci., 2009, 14, 3836-45.
2. Pitsavos, C.; Panagiotakos, D.B.; Menotti, A.; Chrysohoou, C.; Skoumas, J.; Stefanadis, C.; Dontas, A.; Toutouzas, P. Forty-year follow-up of coronary heart disease mortality and its predictors: the Corfu cohort of the seven countries study. Prev. Cardiol., 2003, 6, 155-60.
3. Van den Hoogen, P.C.; Seidell, J.C.; Menotti, A.; Kromhout, D. Blood pressure and long-term coronary heart disease mortality in the Seven Countries study: implications for clinical practice and public health. Eur. Heart J., 2000, 21, 1639-42.
4. Menotti, A.; Keys, A.; Blackburn, H.; Kromhout, D.; Karvonen, M.; Nissinen, A.; Pekkanen, J.; Punsar, S.; Fidanza, F.; Giampaoli, S.; Seccareccia, F.; Buzina, R.; Mohacek, I.; Nedeljkovic, S.; Aravanis, C.; Dontas, A.; Toshima, H.; Lanti, M. Comparison of multivariate predictive power of major risk factors for coronary heart diseases in seven countries: results from eight nations of the Seven Countries Study, 25 year follow up. J. Cardiovasc Risk., 1996, 3, 69-75
5. Jacobs, D.; Adachi, H.; Mulder, I.; Kromhout, D.; Menotti, A.; Nissinen, A.; Blackburn, H.; for the Seven Countries Study Group. Cigarette smoking and mortality risk. 25 year follow up of the Seven Countries Study. Arch. Intern. Med., 1999, 159, 733-40
6. O'Toole, T.E.; Conklin, D.J.; Bhatnagar, A. Environmental risk factors for heart disease. Rev. Environ. Health, 2008; 23(3):167-202.
7. Raupach, T.; Schäfer, K.; Konstantinides, S.; Andreas, S. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur. Heart J., 2006, 27, 386-92.
8. Leone, A.; Balbarini, A. Exposure to passive smoking: a test to predict endothelial dysfunction and atherosclerotic lesions. Angiology, 2008, 59, 220-3.
9. Barnoya, J.; Glantz, S. Cardiovascular effects of secondhand smoke. Nearly as large as smoking. Circulation, 2005, 111, 2684-98.
10. Thun, M.; Henley, J.; Appicella, L. Epidemiologic studies of fatal and non fatal cardiovascular disease and ETS exposure from spousal smoking. Environ. Health perspect., 1999, 107(suppl), 841-846.
11. Whincup, P.H.; Gilg, J.A.; Emberson, J.R.; Jarvis, M.J.; Feyerabend, C.; Bryant, A.; Walker, M.; Cook, D.G. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ, 2004, 329, 200-5.
12. Venn, A.; Briton, J. Exposure to Secondhand smoke and biomarkers of cardiovascular disease risk in never smoking adults. Circulation, 2007, 115, 990-5.
13. Wilkinson, J.D.; Lee, D.J.; Arheart, K.L. Secondhand smoke exposure and C reactive protein levels in youth. Nicotine and tobacco research. 2007, 9, 305-7.
14. Panagiotakos, D.B.; Pitsavos, C.; Chrysohoou, C.; Skoumas, J.; Masoura, C.; Toutouzas, P.; Stefanadis, C.; ATTICA study. Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. Am. J. Med., 2004, 116, 145-50.
15. Pitsavos, C.; Panagiotakos, D.B.; Chrysohoou, C.; Skoumas, J.; Tzioumis, K.; Stefanadis, C.; Toutouzas, P. Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob. Control., 2002, 11, 220-5.
16. WHO Report on tobacco smoke and child health: consultation report. WHO: Geneva, Switzerland, 1999.
17. International Agency for Research on Cancer IARC. Monographs Programmme on the Evaluation of Carcinogenic Risks to Human, 2002; Volume 83; Available at: http://www.iarc.fr [Accessed: December 3, 2008].
18. Schick, S.; Glantz, S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tob. Control., 2005, 14, 396-404.
19. US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: A report of the Surgeon General. Atlanta, G.A: US Department of Health and Human Services, Center for Disease Control and Prevention, Coordinating Center of Health Promotion, National Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health, 2006. Available at http://www.surgeongeneral.gov/library/secondhandsmoke/report/ index.html
20. Pryor, W.A.; Stone, K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate and peroxynitrate. Ann. N Y Acad. Sci., 1993, 686, 12-27.
21. Van der Vaart, H.; Postma, D.S.; Timens, W.; Ten Haccken, N.H.T. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax, 2004, 59, 713-21.
22. Heitzer, T.; Ylä-Herttuala, S.; Luoma, J.; Kurz, S.; Münzel, T.; Just, H.; Olschewski, M.; Drexler, H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation, 1996, 93, 1346-53.
23. Yuan, H.; Wong, L.S.; Bhattacharya, M.; Ma, C.; Zafarani, M.; Yao, M.; Schneider, M.; Pitas, R.E.; Martins-Green, M. The effects of second-hand smoke on biological processes important in atherogenesis. BMC Cardiovasc. Disord., 2007, 7, 1.
24. Ambrose, J.A.; Barua, R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol., 2004, 43, 1731-7.
25. 2-C. Prev. Med., 2004, 38, 637-41.
26. Chelland Campbell, S.C.; Moffatt, R.J; Stamford B. Smoking and smoking cessation-the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis, 2008, 201, 225-35.
27. Boring, L.; Gosling, J.; Cleary, M.; Charo, I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature, 1998, 394, 894-7.
28. Zhang, J.; Liu, Y.; Shi, J.; Larson, D.F.; Watson, R.R. Side-stream cigarette smoke induces dose-response in systemic inflammatory cytokine production and oxidative stress. Exp. Biol. Med., 2002, 227, 823-9.
29. Ikonomidis, I.; Andreotti, F.; Economou, E.; Stefanadis, C.; Toutouzas, P.; Nihoyannopoulos, P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation, 1999, 100, 793-8.
30. Flouris, A.D.; Metsios, G.S.; Carrillo, A.E.; Jamurtas, A.Z.; Gourgoulianis, K.; Kiropoulos, T.; Tzatzarakis, M.N.; Tsatsakis, A.M.; Koutedakis, Y. Acute and short-term effects of secondhand smoke on lung function and cytokine production. Am. J. Respir. Crit. Care Med., 2009, 179, 1029-33.
31. Flouris, A.D.; Metsios, G.S.; Carrillo, A.E.; Jamurtas, A.Z.; Koutedakis, Y.; Tzatzarakis, M.N.; and Tsatsakis, A.M. Effects of passive smoking on resting and exercising humans. Can. J. Appl. Physiol., 2005, 30, S28.
32. Flouris, A.D.; Metsios, G.S.; Jamurtas, A.Z.; Koutedakis, Y. Sexual dimorphism in the acute effects of secondhand smoke on thyroid hormone secretion, inflammatory markers and vascular function. Am. J. Physiol. Endocrinol. Metab., 2008, 294, E456-462.
33. Weber, C.; Schober, A.; Zernecke, A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 1997-2008.
34. Bernhard, D.; Csordas, A.; Henderson, B.; Rossmann, A.; Kind, M.; Wick, G. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J., 2005, 19, 1096-107.
35. Van Hinsbergh, V.W. Arteriosclerosis. Impairment of cellular interactions in the arterial wall. Ann. N. Y. Acad. Sci., 1992, 673, 321-30.
36. Lutgens, E.; Daemen, M.J. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc. Med., 2002, 12, 27-32.
37. Heiss, C.; Amabile, N.; Lee, A.C.; Real, W.M.; Schick, S.F.; Lao, D.; Wong, M.L.; Jahn, S.; Angeli, F.S.; Minasi, P.; Springer, M.L.; Hammond, S.K.; Glantz, S.A.; Grossman, W.; Balmes, J.R.; Yeghiazarians, Y. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J. Am. Coll. Cardiol., 2008, 51, 1760-71.
38. Heiss, C.; Wong, M.L.; Block, V.I.; Lao, D.; Real, W.M.; Yeghiazarians, Y.; Lee, R.J; Springer, M.L. Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J. Cell Physiol., 2008, 215, 366-73.
39. Napoli, C.; Ignarro, L.J. Nitric oxide and atherosclerosis. Nitric Oxide, 2001, 5, 88-97.
40. Jaimes, E.A.; DeMaster, E.G.; Tian, R.X.; Raij, L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc. Biol., 2004, 24, 1031-6.
41. Griendling, K.K.; Sorescu, D.; Ushio-Fukai, M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res., 2000, 86, 494-501.
42. Fujioka, K.; Shibamoto, T. Determination of toxic carbonyl compounds in cigarette smoke. Environ. Toxicol., 2006, 21, 47-54.
43. Park, Y.S; Taniguchi, N. Acrolein induces inflammatory response underlying endothelial dysfunction. A risk factor for Atherosclerosis. Ann. N.Y. Acad. Sci., 2008, 1126, 185-9.
44. Vardavas, C.I.; Kondilis, B.; Travers, M.J.; Petsetaki, E.; Tountas, Y., Kafatos, A.G. Environmental tobacco smoke in hospitality venues in Greece. BMC Public Health, 2007, 7, 302.
45. Pope, C.A. III; Dockery, D.W. Health effects of fine particulate air pollution: lines that connect. J. Air Waste Manag. Assoc., 2006, 56, 709-742.
46. Pai, J.K.; Pischon, T.; Ma, J.; Manson, J.E.; Hankinson, S.E.; Joshipura, K.; Curhan, G.C.; Rifai, N.; Cannuscio, C.C.; Stampfer, M.J.; Rimm, E.B. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med., 2004, 351, 2599-610.
47. Delfino, R.J.; Staimer, N.; Tjoa, T.; Polidori, A.; Arhami, M.; Gillen, D.L.; Kleinman, M.T.; Vaziri, N.D.; Longhurst, J.; Zaldivar, F.; Sioutas, C. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ. Health Perspect., 2008, 116, 898-906.
48. Lassila, R.; Laustiola, K.E. Cigarette smoking and platelet-vessel wall interactions. Prostaglandins Leukot. Essent. Fatty Acids, 1992, 46, 81-6.
49. Shah, P.K. Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. Prog. Cardiovasc. Dis., 2002, 44, 357-68.
50. Fernández-Ortiz, A.; Badimon, J.J.; Falk, E.; Fuster, V.; Meyer, B.; Mailhac, A.; Weng, D.; Shah, P.K.; Badimon, L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J. Am. Coll. Cardiol., 1994, 23, 1562-9.
51. Rubenstein, D.; Jesty, J.; Bluestein, D. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation, 2004, 109, 78-83.
52. Davis, J.W.; Shelton, L.; Watanabe, I.S.; Arnold, J. passive smoking affects endothelium and platelets. Arch. Intern. Med., 1989, 149, 386-9.
53. Langer, H.F.; Gawaz, M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb. Haemost., 2008, 99, 480-6.
54. Law, M.R.; Morris, J.K.; Wald, N.J. Environmental tobacco smoke exposure and ischemic heart disease: an evaluation of the evidence. BMJ, 1997, 315, 973-80.
55. Clark, J.D. 3rd; Wilkinson, J.D.; LeBlanc, W.G.; Dietz, N.A.; Arheart, K.L.; Fleming, L.E.; Lee, D.J. Inflammatory markers and secondhand tobacco smoke exposure among U.S. workers. Am. J. Ind. Med., 2008, 51, 626-32.
56. Libby, P. Inflammation in atherosclerosis. Nature, 2002, 420, 868-74.
57. Ridker, P.M.; Rifai, N.; Rose, L.; Buring, J.E.; Cook, N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med., 2002, 347, 1557-65.
58. Ridker, P.M.; Rifai, N.; Clearfield, M.; Downs, J.R.; Weis, S.E.; Miles, J.S.; Gotto, A.M. Jr; Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med., 2001, 344, 1959-65.
59. Wald, D.S.; Law, M.; Morris, J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 2002, 325, 1202.
60. Cesaroni, G.; Forastiere, F.; Agabiti, N.; Valente, P.; Zuccaro, P.; Perucci, C.A. Effect of the Italian smoking ban on population rates of acute coronary events. Circulation, 2008, 117, 1183-8.
61. Vasselli, S.; Papini, P.; Gaelone, D.; Spizzichino, L.; De Campora, E.; Gnavi, R.; Saitto, C.; Binkin, N.; Laurendi, G. Reduction incidence of myocardial infarction associated with a national legislative ban on smoking. Minerva Cardioangiol., 2008, 56,197-203.
62. Barone-Adesi, F.; Vizzini, L.; Merletti, F.; Richiardi, L. Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur. Heart J., 2006, 27, 2468-72.